News
Public · Published
ESAB Posts Record Q3 Sales of $825 Million, Lowers 2026 Earnings Outlook
ESAB reported record third-quarter 2026 sales of $825 million, up 13.3% from a year earlier, with core organic sales growth of 2.3%. The company lowered its 2026 outlook, now expecting core adjusted EBITDA of $603 million to $607 million and core adjusted EPS of $5.28 to $5.33.
Published:
Updated:
What happened
ESAB reported record third-quarter 2026 sales of $825 million, up 13.3% from a year earlier, with core organic sales growth of 2.3%. The company lowered its 2026 outlook, now expecting core adjusted EBITDA of $603 million to $607 million and core adjusted EPS of $5.28 to $5.33.
Confirmed
Global impact / market context
The lower outlook signals that ESAB expects weaker earnings performance than previously anticipated, despite record sales. If results meet the reduced targets, profit growth may lag revenue growth, affecting the cash the company can generate and investors’ expectations for its business.
Analyst inference
The quarter showed mixed operating results: sales and gross profit rose, and gross margin improved to 39.3%, but operating income fell to $91.9 million from $106.6 million. That combination makes the reduced earnings outlook important when assessing whether growth is translating into stronger operating profit.
Analyst inference
What to watch
- Compare upcoming results with the new 2026 ranges for core adjusted EBITDA and core adjusted EPS to see whether the reduced expectations are being met. Analyst inference
- Watch whether core organic sales growth continues in both the Americas and EMEA & APAC, the two segments where ESAB reported growth this quarter. Analyst inference
- Track operating income alongside sales and gross margin; this quarter, operating income declined even as revenue and gross margin increased. Analyst inference
Evidence
- Original source link unavailable